Can advanced non-small-cell lung cancer be treated with weekly instead of 3-weekly docetaxel?

被引：3
|
作者：
Scagliotti, G. V. [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, S Luigi Hosp Reg Gozole 10, I-10043 Turin, Italy
[2] S Luigi Hosp, Thorac Oncol Unit, Turin, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 06期
关键词：
docetaxel; non-small-cell lung cancer; schedule; survival; toxicity;
D O I：
10.1038/ncponc0510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：294 / 295
页数：2
相关论文
共 50 条
  • [31] WEEKLY DOCETAXEL (TXT) WITH WEEKLY GEMCITABINE AS PROLONGED INFUSION (GEM) IN PATIENTS WITH ADVANCED, PRETREATED NON-SMALL-CELL LUNG CANCER (NSCLC): PRELIMINARY REPORT OF A PHASE II STUDY
    Antonelli, Giovanna
    Priolo, Domenico
    Amadio, Placido
    Colina, Paolo
    Vitale, Felice
    Ferrau, Francesco
    ANNALS OF ONCOLOGY, 2004, 15 : 31 - 31
  • [32] Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens
    Petrioli, R
    Pozzessere, D
    Messinese, S
    Sabatino, M
    Ceciarini, F
    Marsili, S
    Correale, P
    Fiaschi, AI
    Voltolini, L
    Gotti, G
    Francini, G
    LUNG CANCER, 2003, 39 (01) : 85 - 89
  • [33] A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.
    Grecea, D
    Tanasescu, R
    Vasiliniuc, C
    Neamtiu, L
    Ghilezan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
  • [34] Phase II trial of weekly paclitaxel in previously untreated advanced non-small-cell lung cancer
    Yasuda, K
    Igishi, T
    Kawasaki, Y
    Yamamoto, M
    Kato, K
    Matsumoto, S
    Kotani, M
    Sako, T
    Shigeoka, Y
    Sugitani, A
    Histuda, Y
    Shimizu, E
    ONCOLOGY, 2003, 65 (03) : 224 - 228
  • [35] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Weekly docetaxel and vinorelbine as second-line therapy in advanced non-small cell lung cancer
    Huber, R
    Schmidt, M
    Borgmeier, A
    LUNG CANCER, 2005, 49 : S248 - S248
  • [37] Phase I trial of carboplatin and weekly paclitaxel in patients with advanced non-small-cell lung cancer
    Kikuchi, J
    Yamazaki, K
    Kinoshita, I
    Asahina, H
    Imura, M
    Kikuchi, E
    Konishi, J
    Shinagawa, N
    Oki, H
    Dosaka-Akita, H
    Nishimura, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (09) : 505 - 509
  • [38] Weekly docetaxel as a second-line treatment for advanced non-small cell lung cancer (NSCLC).
    García, R
    Pérez, P
    Alfonso, R
    Pérez-Manga, G
    Díaz-Rubio, E
    ANNALS OF ONCOLOGY, 2000, 11 : 116 - 116
  • [39] Our expreience with cisplatin plus weekly docetaxel in patients with advanced non-small cell lung cancer
    Tartarone, Alfredo
    Romano, Gianpiero
    Coccaro, Mariarosa
    Capobianco, Alba
    Bochicchio, Annamaria
    Di Leo, Pasquale
    Iodice, Giovanni
    Mele, Giuseppe
    Matera, Rosella
    Di Renzo, Nicola
    ANNALS OF ONCOLOGY, 2004, 15 : 180 - 180
  • [40] Phase I and Pharmacologic Study of Weekly Bolus Topotecan for Advanced Non-Small-Cell Lung Cancer
    Masuda, Noriyuki
    Matsui, Kaoru
    Negoro, Shunichi
    Takeda, Koji
    Kudoh, Shinzoh
    Nakagawa, Kazuhiko
    Mukaiyama, Akihira
    Arase, Hiroaki
    Yoshida, Pascal
    Ijima, Toshiyuki
    Takada, Minoru
    Fukuoka, Masahiro
    CLINICAL LUNG CANCER, 2010, 11 (04) : 271 - 279
12345